Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2021; 17(12):3000-3012. doi:10.7150/ijbs.60866 This issue Cite

Research Paper

SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway

Bin Zeng1, Zhiwei Sun1, Qiting Zhao1, Doudou Liu2, Hao chen2, Xiaoshuang Li2, H. Rosie Xing2✉, Jianyu Wang1✉

1. Institute of Life Sciences, Chongqing Medical University, Chongqing, China.
2. State Key Laboratory of Ultrasound Engineering in Medicine Co-Founded by Chongqing and the Ministry of Science and Technology, School of Biomedical Engineering, Chongqing Medical University, Chongqing, China.

✉ Corresponding author: wjy2003123com (J.W.), xinglab310com (H.R.X.); Tel.: +86-023-63662443 (J.W.), +86-023-63738563 (H.R.X.); Fax.: +86-023-63662443 (J.W.), +86-023-68486646 (H.R.X.)

Citation:
Zeng B, Sun Z, Zhao Q, Liu D, chen H, Li X, Xing HR, Wang J. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway. Int J Biol Sci 2021; 17(12):3000-3012. doi:10.7150/ijbs.60866. https://www.ijbs.com/v17p3000.htm
Other styles

File import instruction

Abstract

Graphic abstract

Metastasis of melanoma to the distant organs is a multistep process in which the tumor microenvironment (TME) may play an important role. However, the relationship between metastatic progression and TME is intricate. In the present study, using melanoma derivative cell lines OL (oligometastatic) and POL (polymetastatic) that differ in their metastatic colonization capability, we have elucidated a new mechanism involving “SEC23A-PF4-MAPK/ERK axis” in which PF4 transported by COPII hinders metastasis through inhibition of MAPK/ERK signaling pathway. Furthermore, SPARC can act cooperatively to enhance the inhibition of Pf4 on ERK phosphorylation and melanoma cell metastasis. Our findings show the possibility of targeting cancer cell secretome for therapeutic development.

Keywords: melanoma, Sec23a, Pf4, Sparc, MAPK

Citation styles

APA
Zeng, B., Sun, Z., Zhao, Q., Liu, D., chen, H., Li, X., Xing, H.R., Wang, J. (2021). SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway. International Journal of Biological Sciences, 17(12), 3000-3012. https://doi.org/10.7150/ijbs.60866.

ACS
Zeng, B.; Sun, Z.; Zhao, Q.; Liu, D.; chen, H.; Li, X.; Xing, H.R.; Wang, J. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway. Int. J. Biol. Sci. 2021, 17 (12), 3000-3012. DOI: 10.7150/ijbs.60866.

NLM
Zeng B, Sun Z, Zhao Q, Liu D, chen H, Li X, Xing HR, Wang J. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway. Int J Biol Sci 2021; 17(12):3000-3012. doi:10.7150/ijbs.60866. https://www.ijbs.com/v17p3000.htm

CSE
Zeng B, Sun Z, Zhao Q, Liu D, chen H, Li X, Xing HR, Wang J. 2021. SEC23A Inhibit Melanoma Metastatic through Secretory PF4 Cooperation with SPARC to Inhibit MAPK Signaling Pathway. Int J Biol Sci. 17(12):3000-3012.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use